Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€307.70
13.03.23
€350.10
13.03.24
124.73%
14.03.24

Wells Fargo & Company 
13.03.23 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€435.50
11.03.23
-
11.03.24
2.76%
12.03.24

StockNews.com 
11.03.23 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€44.90
18.10.22
-
18.11.26
-44.54%
11.03.24

Probably not worthwhile Investment
Lutz69 
18.10.22 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€140.00
10.03.23
-
10.03.24
17.21%
11.03.24

StockNews.com 
10.03.23 50%
buy
Centene Corp.

Start price
Target price
Perf. (%)
€61.96
09.03.23
€88.83
09.03.24
14.75%
10.03.24

Morgan Stanley 
09.03.23 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€105.80
08.03.23
€120.43
08.03.24
6.62%
09.03.24

Atlantic Securities 
08.03.23 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€104.80
07.03.23
€122.89
07.03.24
8.21%
08.03.24

Mizuho 
07.03.23 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€70.51
07.03.23
€106.82
07.03.24
-23.50%
08.03.24

JMP Securities 
07.03.23 50%
buy
Universal Health Services B

Start price
Target price
Perf. (%)
€117.92
06.03.23
€135.81
06.03.24
37.38%
07.03.24

Deutsche Bank Aktiengesellschaft 
06.03.23 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€47.60
05.01.24
-
05.01.25
0.63%
05.03.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
05.01.24 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€449.75
04.03.23
-
04.03.24
-1.39%
05.03.24

StockNews.com 
04.03.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€299.80
03.03.23
€339.30
03.03.24
142.83%
04.03.24

Citigroup Inc. 
03.03.23 50%
buy
Universal Health Services B

Start price
Target price
Perf. (%)
€120.22
03.03.23
€143.96
03.03.24
33.92%
04.03.24

Credit Suisse Group AG 
03.03.23 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€144.58
28.02.23
-
28.02.24
14.12%
29.02.24

Guggenheim 
28.02.23 50%
buy
Humana Inc.

Start price
Target price
Perf. (%)
€475.10
28.02.23
€528.84
28.02.24
-31.87%
29.02.24

Deutsche Bank Aktiengesellschaft 
28.02.23 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€450.10
28.02.23
€569.31
28.02.24
1.53%
29.02.24

Stephens 
28.02.23 50%
buy
Cigna Corp.

Start price
Target price
Perf. (%)
€274.75
28.02.23
€348.17
28.02.24
12.76%
29.02.24

Stephens 
28.02.23 50%
buy
Henry Schein Inc.

Start price
Target price
Perf. (%)
€74.17
28.02.23
€91.27
28.02.24
-4.57%
29.02.24

Credit Suisse Group AG 
28.02.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€96.82
18.08.23
-
18.08.24
7.52%
15.02.24

Dirk1 
18.08.23 50%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€289.75
29.05.23
-
29.05.24
22.71%
15.02.24

Dirk1 
29.05.23 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€41.98
02.02.24
-
-
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
02.02.24 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€153.36
24.01.23
€160.00
24.01.24
-4.60%
25.01.24

Could be worthwhile Investment >10% per year
melinda 
24.01.23 10%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.96
02.01.24
€80.00
02.02.24
-6.29%
22.01.24

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
02.01.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€325.15
10.01.23
-
10.01.24
77.15%
11.01.24

Lars 
10.01.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
18.12.23 50%